临床试验用品市场－全球产业规模、份额、趋势、机会和预测，按临床阶段、按产品和服务、按治疗用途、按最终用户、按地区和竞争进行细分，2020 年至 2030 年

2024 年全球临床试验用品市场价值为 28.1 亿美元，预计到 2030 年将达到 43.3 亿美元，到 2030 年的复合年增长率为 7.43%。由于全球临床试验的数量和复杂性不断增加，该市场正在经历持续成长。随着製药和生物製药公司致力于加速新疗法的开发，对精简、可靠和合规的供应链的需求也日益加剧。临床试验的地理分布越来越分散，持续时间越来越长，并且受到越来越严格的监管要求。这增加了对高效物流、温控储存和即时追踪系统的需求。自适应试验设计和个人化医疗的采用进一步使供应过程复杂化，促使赞助商寻求具有灵活和可扩展能力的供应合作伙伴。

影响市场的一个重要趋势是数位技术在临床试验物流中的整合。分散和混合试验模式的兴起正在推动赞助商和合约研究组织 (CRO) 采用直接面向患者 (DTP) 的供应策略，并使用数位工具进行监控、预测和库存控制。用于需求规划和资料分析的先进软体平台的实施有助于减少浪费、提高准确性并支援即时决策。智慧包装、资料安全区块链和人工智慧驱动的预测等创新正在被用来提高营运效率并确保法规遵循。

关键市场驱动因素

各治疗领域临床试验数量不断增加

主要市场挑战

管理全球供应链的复杂性

主要市场趋势

供应链数位化和即时监控的采用率不断提高

目录

第 1 章：产品概述

第二章：研究方法

第三章：执行摘要

第四章：顾客之声

第五章：全球临床试验用品市场展望

• 市场规模和预测
  • 按价值
• 市场占有率和预测
  • 依临床阶段（I期、II期、III期、其他）
  • 按产品和服务（製造、仓储和分销、供应链管理）
  • 依治疗用途（肿瘤学、中枢神经系统疾病、心血管疾病、传染病、代谢紊乱、其他）
  • 按最终用户（製药、生物製剂、医疗器材、其他）
  • 按公司分类（2024）
  • 按地区
• 市场地图

第六章：北美临床试验用品市场展望

• 市场规模和预测
• 市场占有率和预测
• 北美：国家分析
  • 美国
  • 墨西哥
  • 加拿大

第七章：欧洲临床试验用品市场展望

• 市场规模和预测
• 市场占有率和预测
• 欧洲：国家分析
  • 法国
  • 德国
  • 英国
  • 义大利
  • 西班牙

第八章：亚太临床试验用品市场展望

• 市场规模和预测
• 市场占有率和预测
• 亚太地区：国家分析
  • 中国
  • 印度
  • 韩国
  • 日本
  • 澳洲

第九章：南美洲临床试验用品市场展望

• 市场规模和预测
• 市场占有率和预测
• 南美洲：国家分析
  • 巴西
  • 阿根廷
  • 哥伦比亚

第十章：中东和非洲临床试验用品市场展望

• 市场规模和预测
• 市场占有率和预测
• MEA：国家分析
  • 南非
  • 沙乌地阿拉伯
  • 阿联酋

第 11 章：市场动态

• 驱动程式
• 挑战

第 12 章：市场趋势与发展

• 合併与收购（如有）
• 产品发布（如有）
• 最新动态

第 13 章：波特五力分析

• 产业竞争
• 新进入者的潜力
• 供应商的力量
• 顾客的力量
• 替代产品的威胁

第 14 章：竞争格局

• Thermo Fisher Scientific Inc.
• Almac Group
• Novo Holdings A/S
• Marken (UPS)
• PCI Pharma Services
• Sharp Services LLC
• Cencora, Inc.
• Myonex
• Parexel International Corporation
• ICON Plc

第 15 章：策略建议

第16章调查会社について・免责事项

The Global Clinical Trial Supplies Market was valued at USD 2.81 billion in 2024 and is expected to reach USD 4.33 billion by 2030, growing at a CAGR of 7.43% through 2030. The market is experiencing sustained growth due to the increasing volume and complexity of clinical trials globally. As pharmaceutical and biopharmaceutical companies aim to accelerate the development of new therapies, the demand for streamlined, reliable, and compliant supply chains has intensified. Clinical trials are becoming more geographically dispersed, longer in duration, and subject to stricter regulatory requirements. This increases the need for efficient logistics, temperature-controlled storage, and real-time tracking systems. The adoption of adaptive trial designs and personalized medicine is further complicating the supply process, prompting sponsors to seek supply partners with flexible and scalable capabilities.

A significant trend shaping the market is the integration of digital technologies in clinical trial logistics. The rise of decentralized and hybrid trial models is pushing sponsors and contract research organizations (CROs) to adopt direct-to-patient (DTP) supply strategies and employ digital tools for monitoring, forecasting, and inventory control. The implementation of advanced software platforms for demand planning and data analytics is helping reduce waste, improve accuracy, and support real-time decision-making. Innovations like smart packaging, blockchain for data security, and AI-driven forecasting are being leveraged to enhance operational efficiency and ensure regulatory compliance.

Key Market Drivers

Rising Number of Clinical Trials Across Therapeutic Areas

The increasing number of clinical trials across various therapeutic areas is a key driver for the Global Clinical Trial Supplies Market. Pharmaceutical, biotechnology, and medical device companies are expanding their research and development pipelines, leading to a surge in clinical research activities. This growth is fueled by increased investments in drug discovery and innovation, along with the growing prevalence of chronic diseases such as cancer, diabetes, cardiovascular disorders, and autoimmune conditions. As new molecules and biologics enter the clinical stage, the demand for efficient and reliable supply chains becomes critical. Sponsors require specialized logistics and packaging services to support complex trial protocols, manage temperature-sensitive products, and ensure the timely delivery of investigational medicinal products (IMPs) to global trial sites.

According to the World Health Organization's International Clinical Trials Registry Platform (ICTRP), the number of newly recruiting trials has steadily increased, with significant growth in regions such as South-East Asia, especially in India. This upward trend in clinical trial activity necessitates robust clinical trial supply chains to handle the increasing complexity and volume of trials. The rise of decentralized trials and direct-to-patient models has further emphasized the need for innovative supply strategies and cold chain infrastructure.

Key Market Challenges

Complexity in Managing Global Supply Chains

Managing global supply chains in the clinical trial supplies market presents significant logistical challenges. Clinical trials are increasingly conducted across multiple countries, complicating supply chain coordination due to varying timelines, different customs regulations, local language requirements, and multiple vendor engagements. Fluctuations in demand forecasts, unpredictable patient enrollment, and protocol amendments further strain supply planning and inventory management. Maintaining drug stability, ensuring timely delivery of investigational products, and preventing stockouts or wastage require highly responsive and adaptive systems. Specialized cold chain logistics and real-time monitoring become even more critical for temperature-sensitive drugs and biologics. As trials move toward decentralized models with direct-to-patient delivery and remote participation, the supply chain must evolve to remain flexible while maintaining quality and compliance. These challenges often add significant costs to trial budgets.

Key Market Trends

Increased Adoption of Supply Chain Digitalization and Real-Time Monitoring

The adoption of supply chain digitalization and real-time monitoring is transforming the operational landscape of the global clinical trial supplies market. Pharmaceutical sponsors and contract research organizations are prioritizing end-to-end visibility to manage the growing complexities of clinical trials. Digital platforms such as Interactive Response Technology (IRT), cloud-based inventory systems, and IoT-enabled tracking tools are becoming essential in enhancing supply chain responsiveness and transparency. These platforms provide real-time insights into drug availability, temperature control, and shipment progress, enabling supply managers to proactively address issues such as stockouts, wastage, and delays.

Real-time monitoring tools ensure compliance with stringent regulatory requirements by capturing data on temperature excursions, delivery confirmations, and chain-of-custody records. This is especially important for sensitive investigational products like biologics and personalized therapies. Predictive analytics integrated with these digital systems can forecast demand fluctuations and help optimize resupply strategies, improving trial continuity. Sponsors gain greater control, reducing risks and enhancing the patient experience by ensuring timely and reliable delivery of trial materials.

Key Market Players

• Thermo Fisher Scientific Inc.
• Almac Group
• Novo Holdings A/S
• Marken (UPS)
• PCI Pharma Services
• Sharp Services LLC
• Cencora, Inc.
• Myonex
• Parexel International Corporation
• ICON Plc

Report Scope:

In this report, the Global Clinical Trial Supplies Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Clinical Trial Supplies Market, By Clinical Phase:

• Phase I
• Phase II
• Phase III
• Others

Clinical Trial Supplies Market, By Product & Services:

• Manufacturing
• Storage & Distribution
• Supply Chain Management

Clinical Trial Supplies Market, By Therapeutic Use:

• Oncology
• CNS Diseases
• Cardiovascular Diseases
• Infectious Disease
• Metabolic Disorders
• Others

Clinical Trial Supplies Market, By End User:

• Pharmaceutical
• Biologics
• Medical Device
• Others

Clinical Trial Supplies Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Turkey

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Clinical Trial Supplies Market.

Available Customizations:

Global Clinical Trial Supplies Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, and Trends

4. Voice of Customer

5. Global Clinical Trial Supplies Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Clinical Phase (Phase I, Phase II, Phase III, Others)
  • 5.2.2. By Product & Services (Manufacturing, Storage & Distribution, Supply Chain Management)
  • 5.2.3. By Therapeutic Use (Oncology, CNS Diseases, Cardiovascular Diseases, Infectious Disease, Metabolic Disorders, Others)
  • 5.2.4. By End User (Pharmaceutical, Biologics, Medical device, Others)
  • 5.2.5. By Company (2024)
  • 5.2.6. By Region
• 5.3. Market Map

6. North America Clinical Trial Supplies Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Clinical Phase
  • 6.2.2. By Product & Services
  • 6.2.3. By Therapeutic Use
  • 6.2.4. By End User
  • 6.2.5. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Clinical Trial Supplies Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Clinical Phase
      • 6.3.1.2.2. By Product & Services
      • 6.3.1.2.3. By Therapeutic Use
      • 6.3.1.2.4. By End User
  • 6.3.2. Mexico Clinical Trial Supplies Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Clinical Phase
      • 6.3.2.2.2. By Product & Services
      • 6.3.2.2.3. By Therapeutic Use
      • 6.3.2.2.4. By End User
  • 6.3.3. Canada Clinical Trial Supplies Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Clinical Phase
      • 6.3.3.2.2. By Product & Services
      • 6.3.3.2.3. By Therapeutic Use
      • 6.3.3.2.4. By End User

7. Europe Clinical Trial Supplies Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Clinical Phase
  • 7.2.2. By Product & Services
  • 7.2.3. By Therapeutic Use
  • 7.2.4. By End User
  • 7.2.5. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. France Clinical Trial Supplies Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Clinical Phase
      • 7.3.1.2.2. By Product & Services
      • 7.3.1.2.3. By Therapeutic Use
      • 7.3.1.2.4. By End User
  • 7.3.2. Germany Clinical Trial Supplies Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Clinical Phase
      • 7.3.2.2.2. By Product & Services
      • 7.3.2.2.3. By Therapeutic Use
      • 7.3.2.2.4. By End User
  • 7.3.3. United Kingdom Clinical Trial Supplies Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Clinical Phase
      • 7.3.3.2.2. By Product & Services
      • 7.3.3.2.3. By Therapeutic Use
      • 7.3.3.2.4. By End User
  • 7.3.4. Italy Clinical Trial Supplies Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Clinical Phase
      • 7.3.4.2.2. By Product & Services
      • 7.3.4.2.3. By Therapeutic Use
      • 7.3.4.2.4. By End User
  • 7.3.5. Spain Clinical Trial Supplies Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Clinical Phase
      • 7.3.5.2.2. By Product & Services
      • 7.3.5.2.3. By Therapeutic Use
      • 7.3.5.2.4. By End User

8. Asia-Pacific Clinical Trial Supplies Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Clinical Phase
  • 8.2.2. By Product & Services
  • 8.2.3. By Therapeutic Use
  • 8.2.4. By End User
  • 8.2.5. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Clinical Trial Supplies Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Clinical Phase
      • 8.3.1.2.2. By Product & Services
      • 8.3.1.2.3. By Therapeutic Use
      • 8.3.1.2.4. By End User
  • 8.3.2. India Clinical Trial Supplies Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Clinical Phase
      • 8.3.2.2.2. By Product & Services
      • 8.3.2.2.3. By Therapeutic Use
      • 8.3.2.2.4. By End User
  • 8.3.3. South Korea Clinical Trial Supplies Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Clinical Phase
      • 8.3.3.2.2. By Product & Services
      • 8.3.3.2.3. By Therapeutic Use
      • 8.3.3.2.4. By End User
  • 8.3.4. Japan Clinical Trial Supplies Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Clinical Phase
      • 8.3.4.2.2. By Product & Services
      • 8.3.4.2.3. By Therapeutic Use
      • 8.3.4.2.4. By End User
  • 8.3.5. Australia Clinical Trial Supplies Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Clinical Phase
      • 8.3.5.2.2. By Product & Services
      • 8.3.5.2.3. By Therapeutic Use
      • 8.3.5.2.4. By End User

9. South America Clinical Trial Supplies Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Clinical Phase
  • 9.2.2. By Product & Services
  • 9.2.3. By Therapeutic Use
  • 9.2.4. By End User
  • 9.2.5. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Clinical Trial Supplies Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Clinical Phase
      • 9.3.1.2.2. By Product & Services
      • 9.3.1.2.3. By Therapeutic Use
      • 9.3.1.2.4. By End User
  • 9.3.2. Argentina Clinical Trial Supplies Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Clinical Phase
      • 9.3.2.2.2. By Product & Services
      • 9.3.2.2.3. By Therapeutic Use
      • 9.3.2.2.4. By End User
  • 9.3.3. Colombia Clinical Trial Supplies Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Clinical Phase
      • 9.3.3.2.2. By Product & Services
      • 9.3.3.2.3. By Therapeutic Use
      • 9.3.3.2.4. By End User

10. Middle East and Africa Clinical Trial Supplies Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Clinical Phase
  • 10.2.2. By Product & Services
  • 10.2.3. By Therapeutic Use
  • 10.2.4. By End User
  • 10.2.5. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Clinical Trial Supplies Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Clinical Phase
      • 10.3.1.2.2. By Product & Services
      • 10.3.1.2.3. By Therapeutic Use
      • 10.3.1.2.4. By End User
  • 10.3.2. Saudi Arabia Clinical Trial Supplies Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Clinical Phase
      • 10.3.2.2.2. By Product & Services
      • 10.3.2.2.3. By Therapeutic Use
      • 10.3.2.2.4. By End User
  • 10.3.3. UAE Clinical Trial Supplies Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Clinical Phase
      • 10.3.3.2.2. By Product & Services
      • 10.3.3.2.3. By Therapeutic Use
      • 10.3.3.2.4. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Porters Five Forces Analysis

• 13.1. Competition in the Industry
• 13.2. Potential of New Entrants
• 13.3. Power of Suppliers
• 13.4. Power of Customers
• 13.5. Threat of Substitute Products

14. Competitive Landscape

• 14.1. Thermo Fisher Scientific Inc.
  • 14.1.1. Business Overview
  • 14.1.2. Company Snapshot
  • 14.1.3. Products & Services
  • 14.1.4. Financials (As Reported)
  • 14.1.5. Recent Developments
  • 14.1.6. Key Personnel Details
  • 14.1.7. SWOT Analysis
• 14.2. Almac Group
• 14.3. Novo Holdings A/S
• 14.4. Marken (UPS)
• 14.5. PCI Pharma Services
• 14.6. Sharp Services LLC
• 14.7. Cencora, Inc.
• 14.8. Myonex
• 14.9. Parexel International Corporation
• 14.10. ICON Plc

15. Strategic Recommendations

16. About Us & Disclaimer